第一单位：
UK NEQAS for Leucocyte Immunophenotyping, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. stuart.scott@ukneqasli.co.uk.;Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. stuart.scott@ukneqasli.co.uk.
作者：
Stuart,Scott [1]
;
Alison,Devonshire [2]
;
Richard,Dillon [3]
;
Christian,Thiede [4]
;
Nicholas C P,Cross [5]
;
Helen E,White [5]
;
Leandro,Lo Cascio [6]
;
Katya,Mokretar [7]
;
Nicola,Potter [8]
;
Christopher S,Hourigan [9]
;
Jerald,Radich [10]
;
Adam,Corner [11]
;
Véronique,Laloux [12]
;
Gemma,Halliday [13]
;
Daniel,Dilks [14]
;
Tom,Morrison [14]
;
Katelyn,Gilmour [15]
;
Ashley,Cartwright [16]
;
Liam,Whitby [16]
作者单位：
UK NEQAS for Leucocyte Immunophenotyping, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. stuart.scott@ukneqasli.co.uk.;Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. stuart.scott@ukneqasli.co.uk.
[1]
Molecular and Cell Biology, National Measurement Laboratory, LGC, Teddington, UK.
[2]
Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas NHS Foundation Trust, London, UK.;Department of Medical and Molecular Genetics, King's College, London, UK.
[3]
University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.;AgenDix, Applied Molecular Diagnostics, GmbH, Dresden, Germany.
[4]
Faculty of Medicine, University of Southampton, Southampton, UK.;Wessex Genomics Laboratory Service, Salisbury District Hospital, Salisbury, UK.
[5]
Diagnostics R&D, Medicines and Healthcare Products Regulatory Agency (MHRA), Potters Bar, UK.
[6]
Cancer Genetics, Guy's Hospital, Synnovis, London, UK.
[7]
Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas NHS Foundation Trust, London, UK.
[8]
Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
[9]
Translational Science & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
[10]
Digital Biology Group, Bio-Rad Laboratories, Pleasanton, CA, USA.
[11]
Translational Science and Precision Diagnostics, QIAGEN, Courtaboeuf, France.
[12]
Horizon Discovery, Diagnostic Reference Standards, Cambridge, UK.
[13]
AccuGenomics, Inc., Wilmington, NC, USA.
[14]
Clinical NGS and Oncology Division, Thermo Fisher, Paisley, UK.
[15]
UK NEQAS for Leucocyte Immunophenotyping, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
[16]
DOI
10.1038/s41375-024-02275-x
PMID
38783160
发布时间
2026-04-06
换一批
